IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Login to save this paper or follow this series

Protección de la competencia en Chile: El Estado vs Laboratorios Chile y Recalcine (1992/93)

  • Edgardo Barandiarán
  • Ricardo Paredes

Este trabajo analiza la denuncia contra Laboratorios Chile y Recalcine por concertación de precios de sus productos farmacéuticos genéricos. Al momento de la denuncia (1992) los dos laboratorios representaban el 82 por ciento del total de las ventas de esos productos en los mercados nacionales. El artículo analiza el proceso y las pruebas del caso para explicar las decisiones opuestas de la Comisión Preventiva y de la Comisión Resolutiva y evaluar si el sistema contribuye a la seguridad jurídica requerida para la libre competencia. En este caso, el proceso fracasó en generar pruebas adecuadas para una decisión fundamentada y las comisiones apreciaron las pocas pruebas con criterios distintos. En consecuencia, sus decisiones no contribuyeron a promover esa seguridad jurídica. No obstante, el análisis del caso es de utilidad para entender el funcionamiento del sistema de protección de la competencia.

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://www.econ.uchile.cl/uploads/publicacion/a2972f23-8511-4e4f-8076-39abd61872c1.pdf
Download Restriction: no

Paper provided by University of Chile, Department of Economics in its series Working Papers with number wp191.

as
in new window

Length:
Date of creation: Jun 2002
Date of revision:
Handle: RePEc:udc:wpaper:wp191
Contact details of provider: Web page: http://www.econ.uchile.cl/

More information through EDIRC

References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:

as in new window
  1. Demougin, Dominique & Fluet, Claude, 2006. "Preponderance of evidence," European Economic Review, Elsevier, vol. 50(4), pages 963-976, May.
  2. F. M. Scherer, 1993. "Pricing, Profits, and Technological Progress in the Pharmaceutical Industry," Journal of Economic Perspectives, American Economic Association, vol. 7(3), pages 97-115, Summer.
Full references (including those not matched with items on IDEAS)

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

When requesting a correction, please mention this item's handle: RePEc:udc:wpaper:wp191. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Rafael Carranza)

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.